IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

N.H. Cho; J.E. Shaw; S. Karuranga; Y. Huang; J.D. da Rocha Fernandes; A.W. Ohlrogge; B. Malanda

doi:10.1016/j.diabres.2018.02.023

journal article Apr 01, 2018

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

N.H. Cho J.E. Shaw S. Karuranga Y. Huang

J.D. da Rocha Fernandes A.W. Ohlrogge B. Malanda

Diabetes Research and Clinical Practice Vol. 138 pp. 271-281 · Elsevier BV

View at Publisher Save 10.1016/j.diabres.2018.02.023

Topics

No keywords indexed for this article. Browse by subject →

References

40

[1]

Baena-Díez "Risk of cause-specific death in individuals with diabetes: a competing risks analysis" Diabetes Care (2016) 10.2337/dc16-0614

[2]

World Health Organization (2009)

[3]

Shaw "Global estimates of the prevalence of diabetes for 2010 and 2030" Diabetes Res Clin Pract (2010) 10.1016/j.diabres.2009.10.007

[4]

Whiting "IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030" Diabetes Res Clin Pract (2011) 10.1016/j.diabres.2011.10.029

[5]

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

K. Ogurtsova, J.D. da Rocha Fernandes, Y. Huang et al.

Diabetes Research and Clinical Practice 2017 10.1016/j.diabres.2017.03.024

[6]

Guariguata "Global estimates of diabetes prevalence for 2013 and projections for 2035" Diabetes Res Clin Pract (2014) 10.1016/j.diabres.2013.11.002

[7]

Blas E, Kuru A, editors. Diabetes: equity and social determinants. In: Equity, social determinants and public health programmes. Geneva: World Health Organization; 2010.

[8]

"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4*4 million participants" Lancet (1980)

[9]

International Diabetes Federation (2000)

[10]

International Diabetes Federation (2003)

[11]

International Diabetes Federation (2006)

[12]

International Diabetes Federation (2009)

[13]

International Diabetes Federation (2011)

[14]

International Diabetes Federation (2013)

[15]

International Diabetes Federation (2015)

[16]

Saaty "Decision making with the analytic hierarchy process" Int J Serv Sci (2008)

[17]

Ogurtsova K, Guariguata L, Whiting D, Unwin N, Weil C, da Rocha Fernandes J., et al. Sensitivity analysis of the global diabetes prevalence estimate in the IDF Diabetes Atlas (Poster). In: International diabetes epidemiology group. Vancouver; 2015.

[18]

World Bank Group. World bank country and lending groups. Data Help Desk; 2017.

[19]

Central Intelligence Agency (2015)

[20]

R Core Team (2012)

[21]

United Nations, Department of Economic and Social Affairs, Population Division. World urbanization prospects: the 2014 revision. New York, USA: United Nations Population Division; 2014.

[22]

Ogurtsova "Incorporating uncertainty measurement in the International Diabetes Federation Diabetes Atlas methodology for estimating global and national prevalence of diabetes in adults (Poster)" Arch Public Health (2015) 10.1186/2049-3258-73-s1-p31

[23]

United Nations, Department of Economic and Social Affairs, Population Division. World population prospects: the 2015 revision. New York, USA: World Population Prospects; 2015.

[24]

Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard (GPE Discussion Paper Series: No. 31). Geneva, Switzerland: World Health Organization; 2001.

[25]

Linnenkamp "The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy" Diabetes Res Clin Pract (2014) 10.1016/j.diabres.2013.11.004

[26]

Ogurtsova (2016)

[27]

da Rocha "IDF diabetes atlas estimates of 2014 global health expenditures on diabetes" Diabetes Res Clin Pract (2016) 10.1016/j.diabres.2016.04.016

[28]

IDF Diabetes Atlas Group "Update of mortality attributable to diabetes for the IDF Diabetes Atlas: estimates for the year 2011" Diabetes Res Clin Pract (2013) 10.1016/j.diabres.2013.02.005

[29]

Roglic "Mortality attributable to diabetes: estimates for the year 2010" Diabetes Res Clin Pract (2010) 10.1016/j.diabres.2009.10.006

[30]

Al-Rubeaan "All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic" Diabetes Res Clin Pract (2016) 10.1016/j.diabres.2016.06.012

[31]

Kang "Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013" Cardiovasc Diabetol (2016) 10.1186/s12933-016-0451-0

[32]

Harding "Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997–2010" Diabetes Care (2014) 10.2337/dc14-0096

[33]

Pildava "The mortality of patients with diabetes mellitus in Latvia 2000–2012" Med Kaunas Lith (2014)

[34]

Bragg "Association between diabetes and cause-specific mortality in rural and urban areas of China" JAMA (2017) 10.1001/jama.2016.19720

[35]

Alegre-Díaz "Diabetes and cause-specific mortality in Mexico City" N Engl J Med (2016) 10.1056/nejmoa1605368

[36]

Kaul "Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: a population-level analysis" Diabet Med J Br Diabet Assoc (2015) 10.1111/dme.12635

[37]

Rivera "The influence of socioeconomic status on future risk for developing Type 2 diabetes in the Canadian population between 2011 and 2022: differential associations by sex" Int J Equity Health (2015) 10.1186/s12939-015-0245-0

[38]

Basu "The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data" PLoS ONE (2013) 10.1371/journal.pone.0057873

[39]

Siegel "Societal correlates of diabetes prevalence: an analysis across 94 countries" Diabetes Res Clin Pract (2012) 10.1016/j.diabres.2011.11.014

[40]

Razavian "Population-level prediction of type 2 diabetes from claims data and analysis of risk factors" Big Data (2015) 10.1089/big.2015.0020

Cited By

5,787

Gestational Diabetes Mellitus and Associated Factors in Rural Areas of Northern Vietnam: Cross-Sectional Survey

Duc Cuong Le, Thị Hiền Nguyễn · 2026

JMIR Public Health and Surveillance

Comparison of Quality-of-Life Outcomes After Percutaneous Coronary Intervention in Diabetic and Non-diabetic Patients With Non-ST-Elevation Myocardial Infarction

Mohmmad D Selim, Jahanara Arzu · 2026

Cureus

Biological Activity of Traditional Foods: Alpha-Amylase and Alpha-Glucosidase Inhibition of Legumes and Cereals

Songül Bayrak · 2026

Türk Doğa ve Fen Dergisi

The association between outdoor noise and temperature exposure with incident type 2 diabetes, and mediation by sleep and body mass index: A multi-cohort analysis

Noreen Z. Siddiqui, Joreintje D. Mackenbach · 2026

Environmental Research

Integrated smartphone-assisted dual-mode glucose biosensor based on GOx-loaded MOF-derived recyclable Nanozymes for portable diabetes monitoring

Shangyi Zhao, Wenlin Li · 2026

Microchemical Journal

l-Cysteine-mediated glucose sensing in human serum by carbon quantum dots entrapped sodium alginate nanocomposite: Maillard reaction-induced fluorescence switching

Swapnita Patra, Krishna Manjari Sahu · 2026

International Journal of Biological...

Chen's Jinshui Pills ameliorate diabetic retinopathy in mice and are associated with intestinal barrier protection and anti-inflammatory effects

Jiazhen Ding, Manyu Zhou · 2026

Journal of Ethnopharmacology

Intravitreal Aflibercept 8 mg for Diabetic Macular Edema

Diana V. Do, Charles C. Wykoff · 2025

Ophthalmology

Biofuel Cell‐Based Potentiostat‐Free Smart Diaper Sensor for Urinary Glucose Monitoring

Muthui Martin Mwaurah, Ajitha Pratheepkumar Anuja · 2025

Analysis & Sensing

In vitro and in silico Anti-diabetes mechanism of phytochemicals from Curculigo pilosa and its pharmacokinetic profiling via α-amylase inhibition

Damilola A. Omoboyowa, Temitope C. Aribigbola · 2025

Aspects of Molecular Medicine

The immunology of diabetic cardiomyopathy

Ming Song, Honggang Dai · 2025

Frontiers in Endocrinology

Predictive Role of Complete Blood Count-Derived Inflammation Indices and Optical Coherence Tomography Biomarkers for Early Response to Intravitreal Anti-VEGF in Diabetic Macular Edema

Ece Ergin, Ana Maria Dascalu · 2025

Biomedicines

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

David M Brown, David S Boyer · 2024

The Lancet

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2025

Nuha A. ElSayed, Rozalina G. McCoy · 2024

Diabetes Care

Macrophage and Neutrophil Dysfunction in Diabetic Wounds

Shannon M. Clayton, Sasha H. Shafikhani · 2024

Advances in Wound Care

Advanced Neuromorphic Applications Enabled by Synaptic Ion‐Gating Vertical Transistors

Leandro Merces, Letícia Mariê Minatogau Ferro · 2024

Advanced Science

Trends in rates of hospitalisation for infection in people with diabetes and the general population

Berhanu Elfu Feleke, Jonathan E. Shaw · 2024

Diabetic Medicine

Distinct microbiome of tongue coating and gut in type 2 diabetes with yellow tongue coating

Yao Wang, Jiqing Li · 2024

Heliyon

Exposure to cadmium and lead is associated with diabetic kidney disease in diabetic patients

Yuan Zhang, Xiaoyu Gong · 2024

Environmental Health

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

Carolyn E. Cesta, Ran Rotem · 2024

JAMA Internal Medicine

Metrics

5,787

Citations

40

References

Details

Published: Apr 01, 2018
Vol/Issue: 138
Pages: 271-281
License: View

Authors

Charles University, Faculty of Mathematics and Physics

J

J.D. da Rocha Fernandes

Cite This Article

N.H. Cho, J.E. Shaw, S. Karuranga, et al. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271-281. https://doi.org/10.1016/j.diabres.2018.02.023

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

You May Also Like